respiratori
tract
infect
lead
caus
death
worldwid
laboratori
test
requir
identifi
underli
etiolog
agent
respiratori
infect
commonli
present
similar
sign
symptom
xtag
respiratori
viral
panel
xtag
rvp
fast
multiplex
molecular
assay
respiratori
viral
infect
manufactur
luminex
corp
austin
tx
usa
routin
use
clinic
laboratori
detect
respiratori
virus
decemb
luminex
introduc
nxtag
respiratori
pathogen
panel
nxtag
rpp
follow
approv
unit
state
food
drug
administr
nxtag
rpp
xtag
rvp
fast
number
viral
target
includ
influenza
viru
strain
influenza
b
viru
parainfluenza
viru
type
piv
enterovirusrhinoviru
coronavirus
respiratori
syncyti
viru
rsv
b
metapneumoviru
adenoviru
bocaviru
nxtag
rpp
two
addit
atyp
bacteri
target
name
mycoplasma
pneumonia
chlamydophila
pneumonia
recent
studi
compar
perform
new
nxtag
rpp
respiratori
panel
biofir
filmarray
rvp
anyplex
ii
xtag
rvp
fast
overal
report
demonstr
nxtag
rpp
least
compar
better
compar
assess
clinic
perform
nxtag
rpp
versu
xtag
rvp
fast
detect
respiratori
virus
studi
approv
local
institut
ethic
board
nation
healthcar
group
domainspecif
review
board
refer
perform
may
decemb
deidentifi
clinic
respiratori
sampl
submit
molecular
diagnosi
centr
singapor
nation
univers
hospit
includ
see
tabl
list
viral
pathogen
includ
addit
extern
qualiti
assess
eqa
sampl
colleg
american
pathologist
cap
infecti
diseas
respiratori
panel
receiv
year
test
tabl
total
nucleic
acid
extract
qiagen
viru
mini
kit
biorobot
extractor
qiagen
hilden
germani
sampl
initi
test
xtag
rvp
fast
part
routin
clinic
servic
brief
extract
nucleic
acid
use
target
amplif
multiplex
revers
transcript
pcr
rtpcr
pcr
product
hybrid
bead
mix
next
report
dye
ad
new
reaction
vessel
seal
incub
amplif
hybridizationincub
perform
appli
biosystem
veriti
thermal
cycler
thermo
fisher
scientif
wohlen
switzerland
per
manufactur
recommend
signal
acquisit
perform
magpix
instrument
luminex
corp
test
extract
nucleic
acid
immedi
frozen
test
residu
frozen
archiv
sampl
retriev
test
nxtag
rpp
closedtub
nucleic
acid
assay
contain
premix
lyophil
reagent
target
amplif
pcr
product
hybridizationincub
detect
procedur
carri
accord
manufactur
instruct
extract
nucleic
acid
ad
resuspend
preplat
lyophil
bead
reagent
vessel
multiplex
rtpcr
bead
hybrid
report
dye
incub
perform
veriti
thermal
cycler
per
manufactur
recommend
final
vessel
place
onto
magpix
instrument
signal
acquisit
discord
result
found
two
assay
particular
sampl
third
laboratorydevelop
clinic
valid
use
confirm
laboratorydevelop
rvp
methodolog
describ
supplement
file
scenario
result
concurr
two
three
method
consid
true
concord
rate
cohen
kappa
coeffici
two
luminex
assay
determin
use
graphpad
quickcalc
graphpad
la
jolla
ca
usa
clinic
sampl
test
concord
result
neg
posit
respect
discord
sampl
contain
metapneumoviru
enterovirusrhinoviru
coronaviru
eight
influenza
virus
test
posit
laboratorydevelop
rvp
assay
thu
consid
true
posit
tabl
overal
concord
rate
two
luminex
assay
cohen
kappa
coeffici
confid
interv
ci
indic
substanti
degre
agreement
discord
sampl
xtag
rvp
fast
miss
eight
influenza
virus
one
coronaviru
nxtag
rpp
miss
one
enterovirusrhinoviru
one
metapneumoviru
basi
cap
result
nxtag
rpp
xtag
rvp
fast
correctli
identifi
pathogen
sampl
test
nxtag
rpp
detect
presenc
pneumonia
one
sampl
includ
studi
find
confirm
use
commerci
realtim
pcr
assay
mycoplasma
venor
gem
qep
mycoplasma
detect
kit
minerva
biolab
gmbh
berlin
germani
subsequ
sensit
test
use
lyophil
colonyform
unit
cfu
sensit
standard
minerva
biolab
gmbh
show
nxtag
assay
capabl
detect
pneumonia
strain
cfuspcr
assess
clinic
perform
new
nxtag
rpp
xtag
rvp
fast
use
repres
panel
viral
pathogen
neg
notabl
season
influenza
viru
detect
local
popul
includ
studi
strain
appear
complet
replac
pandem
influenza
viru
sinc
overal
assay
show
compar
sensit
specif
viral
target
except
influenza
viru
notabl
xtag
rvp
fast
show
poor
perform
influenza
subtyp
may
due
primer
mismatch
best
knowledg
one
studi
compar
perform
nxtag
rpp
xtag
rvp
fast
howev
miss
detect
influenza
report
unclear
whether
miss
detect
xtag
rvp
fast
relat
variant
viru
report
center
diseas
control
prevent
atlanta
recent
nonetheless
inabl
simultan
detect
subtyp
virus
major
hindranc
clinic
laboratori
return
test
result
within
establish
turnaroundtim
influenza
viru
clinic
signific
respiratori
pathogen
therefor
abil
rapidli
provid
subtyp
inform
import
outbreak
epidemiolog
investig
contrast
influenza
primer
nxtag
rpp
updat
detect
untyp
strain
studi
suggest
exist
xtag
rvp
fast
user
switch
nxtag
rpp
better
sensit
influenza
without
signific
drop
sensit
respiratori
viral
target
enterovirusrhinoviru
infect
compris
studi
popul
howev
inabl
luminex
assay
distinguish
enteroviru
rhinoviru
infect
patient
lower
overal
clinic
util
distinct
clinic
import
particularli
septic
workup
neonat
vulnerableimmunocompromis
patient
enterovirus
dissemin
caus
system
infect
involv
multipl
organ
wherea
rhinovirus
gener
rvp
assay
detect
multipl
viral
target
simultan
studi
reveal
nine
case
coinfect
coinfect
involv
enterovirusrhinoviru
consist
result
previou
studi
case
involv
enterovirusrhinoviru
rsv
limit
current
studi
number
per
target
rel
low
influenza
b
parainfluenza
viru
type
coronavirus
adenoviru
bocaviru
may
suffici
reflect
true
diagnost
capabl
two
assay
low
detect
rate
virus
observ
elsewher
addit
unabl
evalu
perform
bacteri
panel
nxtag
rpp
addit
bacteri
target
detect
xtag
rvp
fast
laboratorydevelop
rvp
furthermor
detect
singl
case
pneumonia
nxtag
rpp
experiment
xtag
rvp
fast
assay
turnaround
time
hr
sampl
howev
need
manipul
postamplif
product
present
inher
risk
laboratori
contamin
moreov
need
remov
seal
vessel
detect
present
anoth
potenti
sourc
sampl
crosscontamin
lead
falseposit
besid
crosscontamin
high
background
nois
fig
anoth
sourc
falseposit
commonli
associ
luminex
beadbas
suspens
array
technolog
due
suboptim
hybrid
condit
involv
temperatur
diverg
oper
variat
contrast
nxtag
rpp
closedtub
onestep
system
abolish
need
postamplif
product
manipul
remov
seal
handson
time
significantli
reduc
simplifi
workflow
allevi
process
variat
give
turnaround
time
hr
sampl
overal
streamlin
workflow
minim
crosscontamin
background
nois
howev
initi
extract
nucleic
acid
use
resuspend
preplat
lyophil
bead
reagent
repeat
pipet
caus
possibl
crossov
contamin
final
nxtag
rpp
process
sampl
per
run
without
wast
addit
consum
reagent
flexibl
throughput
cater
need
laboratori
differ
andor
variabl
volum
demand
conclus
two
luminex
assay
perform
compar
pathogen
nxtag
rpp
advantag
abl
detect
atyp
bacteria
better
diagnost
sensit
certain
virus
